Skip to main content
. 2023 Apr 21;13:6554. doi: 10.1038/s41598-023-32699-x

Table 3.

Clinical variables and patient-outcomes grouped by fibrotic changes on CT images at short-term follow-up.

Parameter Fibrotic changes
n = 58
No fibrotic changes
n = 36
T-test/Chi-square
p = 0.05
Age, years, mean ± SD 55.5 ± 13 49.4 ± 12.4 p =0.018
Male, n (%) 37 (64) 11 (31) p = 0.003
BMI, kg/m2, mean ± SD 33 ± 7 37.6 ± 9.5 p = 0.035
Charlson comorbidity index, mean ± SD 2.8 ± 1.9 2.3 ± 2.1 p = 0.135
MV duration, days, mean ± SD 17.6 ± 10.5 15.0 ± 14 p = 0.067
Fi02, highest in first 72 h, mean ± SD 87 ± 17 87 ± 20 p = 0.965
PEEP, highest in first 72 h, mean ± SD 12.6 ± 3.2 13.5 ± 4.6 p = 0.315
Oxygenation (HFNC + MV, days, mean ± SD 21 ± 11 16 ± 14 p = 0.003
SOFA, mean ± SD 11.5 ± 2.5 10.6 ± 2.4 p = 0.089
RASS in first 72 h, mean ± SD  − 3.5 ± 1.2  − 2.8 ± 1.3 p = 0.005
ICU LOS, mean ± SD 24.4 ± 14 19.3 ± 15 p = 0.015
Hospital LOS, mean ± SD 34 ± 16 27 ± 18 p = 0.016
90-day readmit/ER, yes, n (%) 12 (21) 10 (28) p = 0.460
Spirometry (n) 52 27
 FEV1 2.2 ± 0.7 2.1 ± 0.7 t = 0.2, p = 0.84
 FEV1% predicted 67 ± 17 67 ± 19 t = 0.2, p = 0.86
 FVC 2.7 ± 0.9 2.7 ± 0.9 t = 0.5, p = 0.61
 FVC % predicted 64 ± 19 70 ± 20 t = 1.5, p = 0.13
6MWT (n) 39 20
 Distance, meters, mean ± SD 228.6 ± 121 243 ± 162 t = 0.10, p = 0.92
 % of predicted, % mean ± SD 44 ± 24 46 ± 31 t = 0.09, p = 0.92
QOL and cognitive outcomes (n) n = 48 n = 28
MOCA, mean ± SD 25 ± 3.3 25 ± 4.0 t = 0.54, p = 0.589
 MCI (cutoff < 25) yes/n (%) 18 (38) 13 (46) p = 0.468
 EQ-5D VAS, mean ± SD 67 ± 19 62 ± 17 t = 1.08, p = 0.281
Emotional outcomes (n) n = 48 n = 28
 IES-R, mean ± SD 26 ± 22 36 ± 25 t = 1.688, p = 0.098
 IES-R cutoff > 33, yes, n (%) 15 (31) 17 (61) p = 0.016
 HADS-anxiety, mean ± SD 6.9 ± 5.2 8.3 ± 5.0 t = 1.10, p = 0.275
 HADS-anxiety cutoff > 8, yes, n (%) 18 (38) 13 (46) p = 0.477
 HADS-depression, mean ± SD 6.0 ± 4.5 7.7 ± 4.9 t = 1.52, p = 0.135
 HADS-depression cutoff > 8, yes, n (%) 14 (29) 11 (39) p = 0.450

MOCA Montreal Cognitive Assessment, MCI mild cognitive impairment, VAS visual analog scale, HADS hospital anxiety and depression scale, IES-R impact of events scale-revised, PTSD post-traumatic stress disorder.